Comparison
How Pharma Observatory compares
A plain guide to Pharma Observatory and 6 other tools in biopharma intelligence. We are one of the products discussed, so every statement about another product comes from that vendor's own pages, linked and dated.
Individual plan, $249/seat/mo. Card required.
Who this guide is from
Pharma Observatory is a connected model of public biomedical evidence. Trials, drugs, companies, people and sites are each matched into one record, and figures on record pages link to their source records. It holds 94+ data sources, 930 million+ source records, 600,000+ trials, 380,000+ investigators, 1 million+ research sites, 350,000+ organizations, 790,000+ publications (rounded down to two significant figures; each is defined on the data page). It is made for people who need to look something up about a trial, a drug or a company and then check where the answer came from.
We publish this comparison and are one of the products discussed. Some of the others below are a different kind of tool, not a competing version of this one, and each of their pages says where they are the better fit.
To read the page: start with the questions, glance at the quick comparison, then open the one-on-one page for the tools you are actually weighing. For price, sign-up and trial, No means none is published on the pages we checked, which we read as not offered. For every other point, Not published means we did not find it on their pages.
How to choose
6 questions worth putting to any vendor. Each answer is read from the facts on this page.
-
Is the price published?
- Pharma Observatory
- From $249/seat/mo
- AlphaSense
- Quote-only
- Citeline
- No
- Clarivate Cortellis
- No
- DrugPatentWatch
- Starter $1,000/month
- Evaluate
- Quote-only
- GlobalData
- No
Scope: Published prices are not like-for-like plans. Ours is the Individual plan, $249/seat/mo (a per-seat monthly price). On DrugPatentWatch's pricing page, Starter is $1,000 per month, no unit stated (basic searches only, limited monthly searches, no export, no alerts) and Professional is $3,000 per month, single user (unlimited and advanced searches, export, alerts, Deep Research Engine).
-
Can I sign up without a sales call?
- Pharma Observatory
- Yes: Individual and Team
- AlphaSense
- No
- Citeline
- No
- Clarivate Cortellis
- No
- DrugPatentWatch
- Yes
- Evaluate
- No
- GlobalData
- No
-
Is there a trial?
- Pharma Observatory
- 14-day trial, card required
- AlphaSense
- Free trial by request form
- Citeline
- No
- Clarivate Cortellis
- No
- DrugPatentWatch
- Paid one-week trial
- Evaluate
- No
- GlobalData
- No
-
What content is behind it?
- Pharma Observatory
- 94+ sources, 930 million+ source records
- AlphaSense
- 500+ million documents
- Citeline
- 400,000+ trials, 530,000+ investigators
- Clarivate Cortellis
- Not published
- DrugPatentWatch
- Eight modules, 134 countries
- Evaluate
- Consensus forecasts and asset valuation
- GlobalData
- Not published
Scope: These are not the same unit. Each is that product's own published description of its content, and counts are not defined the same way by every vendor. Ours are rounded down to two significant figures and defined on the data page.
-
Can an AI agent reach it?
- Pharma Observatory
- Every paid plan; we issue the credential
- AlphaSense
- Not published
- Citeline
- Not published
- Clarivate Cortellis
- Announced for CRI customers
- DrugPatentWatch
- Not published
- Evaluate
- Not published
- GlobalData
- Via account manager
-
Is there an API?
- Pharma Observatory
- Enterprise plan, OpenAPI documented
- AlphaSense
- Agent API, on request
- Citeline
- Drug Development, Events, Forecast APIs
- Clarivate Cortellis
- Drugs API, paid license
- DrugPatentWatch
- Not published
- Evaluate
- Not published
- GlobalData
- REST API listed
Quick comparison
One line each. The source and the date we checked it sit under every competitor value.
| Product | What it is | Published price | Self-serve sign-up | Trial | AI agent access |
|---|---|---|---|---|---|
| Pharma Observatory | Connected public-source evidence | From $249/seat/mo verify | Yes: Individual and Team verify | 14-day trial, card required verify | Every paid plan; we issue the credential verify |
| AlphaSense | AI market intelligence searchsource | Quote-onlysource | Nosource | Free trial by request formsource | Not published |
| Citeline | Clinical trial and pipeline datasource | Nosource | Nosource | Nosource | Not published |
| Clarivate Cortellis | Modular life-sciences intelligencesource | Nosource | Nosource | Nosource | Announced for CRI customerssource |
| DrugPatentWatch | Drug patents and exclusivitysource | Starter $1,000/monthsource | Yessource | Paid one-week trialsource | Not published |
| Evaluate | Forecasts and asset valuationsource | Quote-onlysource | Nosource | Nosource | Not published |
| GlobalData | Pharma and healthcare intelligencesource | Nosource | Nosource | Nosource | Via account managersource |
Scope: Published prices are not like-for-like plans. Ours is the Individual plan, $249/seat/mo (a per-seat monthly price). On DrugPatentWatch's pricing page, Starter is $1,000 per month, no unit stated (basic searches only, limited monthly searches, no export, no alerts) and Professional is $3,000 per month, single user (unlimited and advanced searches, export, alerts, Deep Research Engine).
The tools, one at a time
Each page puts the two products side by side, with every fact sourced.
-
AlphaSense
Horizontal AI market intelligence (filings, transcripts, broker research, expert calls)
Best for: Monitoring pipelines, benchmarking competitors and analyzing the market landscape with AI over expert interviews, broker research, clinical trial documents and regulatory filings, which is how its life sciences page describes the product. source
AlphaSense says it "is not a pharmaceutical database, nor is it intended only for life sciences customers", and describes itself as "an AI-driven market research platform" with a library of premium and proprietary content. source
-
Citeline
Clinical development and pipeline intelligence (Trialtrove, Pharmaprojects, Sitetrove)
Best for: Trial feasibility and site selection. Its feasibility page is headed "Select the right countries, sites, and investigators for your trial". source
Citeline sells Trialtrove, Pharmaprojects and Sitetrove. It describes Trialtrove as "curated data on trial design, enrollment, and execution" that clinical teams use to plan and benchmark trials. source
-
Clarivate Cortellis
Modular life-sciences intelligence (regulatory, clinical, deals, generics, Cortellis Drug Discovery Intelligence)
Best for: Teams working across portfolio strategy, research and development, and commercialization. Its life sciences pages are organized under those headings, with Cortellis as the intelligence platform. source
Clarivate says it helps customers "throughout the drug and device lifecycle" through "trusted intelligence platforms including Cortellis and DRG, proprietary data and deep domain expertise". source
-
DrugPatentWatch
Patent and exclusivity specialist
Best for: Predicting generic entry, patent risk and revenue shifts. Its homepage headline reads "Predict Generic Entry, Patent Risk, and Revenue Shifts". source
DrugPatentWatch describes itself as "Authoritative biopharmaceutical intelligence" covering "patents, pipelines, litigation, pricing, and global market opportunities". source
-
Evaluate
Consensus forecasts, market sizing and asset valuation
Best for: Teams that want consensus analyst forecasts and asset-valuation data delivered into their own systems. source
Evaluate's data-feeds page describes consensus analyst forecasts and asset-valuation data, which can be delivered through Snowflake and flat files, with selected APIs also available across the wider portfolio. source
-
GlobalData
Molecule-to-market pipelines, epidemiology, forecasts, deals and trials
Best for: Teams that want its intelligence delivered "directly into the systems your organization already runs on", which is how its Direct Data Solutions page describes the offer. source
GlobalData Healthcare's page describes "over 290 proprietary datasets built on primary research and in-house methodologies", "validated and analyzed by over 2,000 experts and healthcare market specialists". source
Where these facts come from
Every statement about another product is taken from that vendor's own website, with the page linked and the date we read it. We do not use review sites, price aggregators or other third-party figures, and we do not estimate. Our own column is read from this application each time the page loads, so it cannot drift from the product.
Prices and features change. Every fact here is re-checked at least every 90 days; the newest check was 2026-10-09 (4 days ago). If you spot something out of date, the vendor's linked page is the one to trust, and we would like to know.
Other names are trademarks of their respective owners; no affiliation or endorsement is implied.